STEPHANIE DICLEMENTE: Open Payments
NPI 1821311440 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$119 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $119
Food & beverage: $119
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Boston Scientific Corporation | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: LEQVIO, ACCOLADE SR, FARXIGA, NEXLETOL.
Industry payments across PA — which companies pay providers there.
